The inhibition of NLRP3 inflammasome pathway, such as Ginsenoside Rg1, low methoxyl pectin, and Bay11-7082, may be a potential therapeutic strategy for autoimmune diseases (Table 2). The gene discussed is NLRP3; the disease is autoimmune disease.